Squarepoint’s Rockwell Medical RMTI Stock Holding History

Squarepoint’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,317	Closed	-$45.1K	–	4899
2025 Q2	$45.1K	Sell	5,317 -7,843	-60%	-$80K	﹤0.01%	4320
2025 Q1	$149K	Buy	13,160 +8,605	+189%	+$156K	﹤0.01%	4110
2024 Q4	$92.9K	Buy	+4,555	New	+$133K	﹤0.01%	4717
2024 Q2	–	Sell	-5,699	Closed	-$94.6K	–	4552
2024 Q1	$94.6K	Buy	5,699 +3,247	+132%	+$47.2K	﹤0.01%	3806
2023 Q4	$46.3K	Buy	+2,452	New	+$46.1K	﹤0.01%	3858
2021 Q1	–	Sell	-2,498	Closed	-$278K	–	3537
2020 Q4	$278K	Buy	2,498 +37	+2%	+$4.14K	﹤0.01%	2264
2020 Q3	$290K	Buy	2,461 +2,317	+1,609%	+$401K	﹤0.01%	1822
2020 Q2	$31K	Buy	+144	New	+$34K	﹤0.01%	2139
2018 Q3	–	Sell	-199	Closed	-$108K	–	2187
2018 Q2	$108K	Buy	+199	New	+$119K	﹤0.01%	1637
2018 Q1	–	Sell	-206	Closed	-$132K	–	2073
2017 Q4	$132K	Buy	+206	New	+$145K	﹤0.01%	1904

Other funds holding RMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Squarepoint's RMTI Position: Q3 2025 in Review

Squarepoint sold out of Rockwell Medical (RMTI) in Q3 2025, closing a stake of 5,317 shares — an estimated $45.1K sold.

Squarepoint first reported a position in RMTI in Q4 2017 and held it in 10 quarters. The position peaked at $290K in Q3 2020. 36 funds tracked by Wall St. Rank hold RMTI as of Q3 2025.

Squarepoint reported no remaining Rockwell Medical position as of Q3 2025 after selling out during the quarter.
Squarepoint sold 5,317 Rockwell Medical shares in Q3 2025, an estimated $45.1K.
Squarepoint first reported a position in Rockwell Medical in Q4 2017 and held it in 10 quarters.
Squarepoint's Rockwell Medical position peaked at $290K in Q3 2020.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.